HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by REID, G. C. Articles by HOPKINS, M. P. Search for Related Content PubMed PubMed Citation Articles by REID, G. C. Articles by HOPKINS, M. P.

The Role of Pelvic Exenteration for Sarcomatous Malignancies

From the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, and the Department of Pathology, University of Michigan Medical Center, Ann Arbor, Michigan

Abstract

Pelvic exenteration, although performed most frequently for recurrent squamous cell carcinoma of the cervix and vagina, has been used in selected patients with pelvic sarcoma. Nine patients with various histologic types of sarcoma treated by pelvic exenteration are reported. During this 23-year time period, 46 patients with sarcoma were evaluated for possible exenteration. Patients with embryonal rhabdomyosarcoma (sarcoma botryoides) were excluded because these pediatric tumors are now treated with less radical operative procedures, plus radiation and chemotherapy. Six patients had exenteration as primary treatment, and three patients had exenteration as secondary treatment. Four patients developed recurrent disease (mean 5.2 months), and all four died of disease. Five patients were alive at 5 and 10 years, for an absolute survival of 55%. All three patients with mixed mesodermal tumors died of recurrent disease, compared with 83% survival for patients with other sarcoma types. Pelvic exenteration may play a limited but important role in the therapy of pelvic sarcoma.

This article has been cited by other articles:

				T. M. Pawlik, J. M. Skibber, and M. A. Rodriguez-Bigas Pelvic Exenteration for Advanced Pelvic Malignancies Ann. Surg. Oncol., May 1, 2006; 13(5): 612 - 623. [Full Text] [PDF]